Research Article | Open Access
Guoliang Cui, Yuebo Zhang, Cindy Liu, Sheri Skinner, Ying Qin, "Pancreatic Cancer Suppression by Natural Polyphenols", Scholarly Research Exchange, vol. 2008, Article ID 540872, 6 pages, 2008. https://doi.org/10.3814/2008/540872
Pancreatic Cancer Suppression by Natural Polyphenols
Resveratrol and quercetin are polyphenols abundant in frequently consumed fruits, vegetables, and red wine. They have many biological activities, including antitumor, anti-inflammation, and antioxidation effects. This study evaluates the chemopreventive potential of resveratrol and quercetin against pancreatic cancer and investigates some of the underlying mechanisms. We report that resveratrol and quercetin suppress pancreatic tumor growth and that resveratrol extends life expectancy in a tumor bearing mouse model. Further, these two polyphenols inhibit growth of pancreatic cancer cell line, Panc02, in vitro. Results suggest that mechanisms may include induction of expression of caspase 3/8, causing DNA fragmentation, and arresting cells in G1 phase of the cell cycle. Cell invasion data reveals that both resveratrol and quercetin are able to decrease tumor cell invasion through an endothelial barrier. These data suggest that resveratrol and quercetin may be beneficial in pancreatic cancer treatment and metastasis prevention.
- A. Nakao, T. Fujii, H. Sugimoto et al., “Oncological problems in pancreatic cancer surgery,” World Journal of Gastroenterology, vol. 12, no. 28, pp. 4466–4472, 2006.
- D. Li, K. Xie, R. Wolff, and J. L. Abbruzzese, “Pancreatic cancer,” The Lancet, vol. 363, no. 9414, pp. 1049–1057, 2004.
- G. Garcea, H. Doucas, W. P. Steward, A. R. Dennison, and D. P. Berry, “Hypoxia and angiogenesis in pancreatic cancer,” ANZ Journal of Surgery, vol. 76, no. 9, pp. 830–842, 2006.
- L. O. Dragsted, M. Strube, and T. Leth, “Dietary levels of plant phenols and other non-nutritive components: could they prevent cancer?,” European Journal of Cancer Prevention, vol. 6, no. 6, pp. 522–528, 1997.
- D. M. Goldberg, S. E. Hahn, and J. G. Parkes, “Beyond alcohol: beverage consumption and cardiovascular mortality,” Clinica Chimica Acta, vol. 237, no. 1-2, pp. 155–187, 1995.
- K. Subbaramaiah, W. J. Chung, P. Michaluart et al., “Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells,” The Journal of Biological Chemistry, vol. 273, no. 34, pp. 21875–21882, 1998.
- T. Kaneyuki, Y. Noda, M. G. Traber, A. Mori, and L. Packer, “Superoxide anion and hydroxyl radical scavenging activities of vegetable extracts measured using electron spin resonance,” IUBMB Life, vol. 47, no. 6, pp. 979–989, 1999.
- T. Wallerath, D. Poleo, H. Li, and U. Förstermann, “Red wine increases the expression of human endothelial nitric oxide synthase: a mechanism that may contribute to its beneficial cardiovascular effects,” Journal of the American College of Cardiology, vol. 41, no. 3, pp. 471–478, 2003.
- Z. Cao, J. Fang, C. Xia, X. Shi, and B.-H. Jiang, “trans--trihydroxystibene inhibits hypoxia-inducible factor 1 and vascular endothelial growth factor expression in human ovarian cancer cells,” Clinical Cancer Research, vol. 10, no. 15, pp. 5253–5263, 2004.
- J. A. Baur and D. A. Sinclair, “Therapeutic potential of resveratrol: the in vivo evidence,” Nature Reviews Drug Discovery, vol. 5, no. 6, pp. 493–506, 2006.
- S. Fulda and K.-M. Debatin, “Resveratrol modulation of signal transduction in apoptosis and cell survival: a mini-review,” Cancer Detection and Prevention, vol. 30, no. 3, pp. 217–223, 2006.
- D. Delmas, C. Rébé, S. Lacour et al., “Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells,” The Journal of Biological Chemistry, vol. 278, no. 42, pp. 41482–41490, 2003.
- M. Jang, L. Cai, G. O. Udeani et al., “Cancer chemopreventive activity of resveratrol, a natural product derived from grapes,” Science, vol. 275, no. 5297, pp. 218–220, 1997.
- L. Tessitore, A. Davit, I. Sarotto, and G. Caderni, “Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and expression,” Carcinogenesis, vol. 21, no. 8, pp. 1619–1622, 2000.
- S. Banerjee, C. Bueso-Ramos, and B. B. Aggarwal, “Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-B, cyclooxygenase 2, and matrix metalloprotease 9,” Cancer Research, vol. 62, no. 17, pp. 4945–4954, 2002.
- D. W. Lamson and M. S. Brignall, “Antioxidants and cancer III: quercetin,” Alternative Medicine Review, vol. 5, no. 3, pp. 196–208, 2000.
- M. Russo, R. Palumbo, I. Tedesco et al., “Quercetin and anti-CD95(Fas/Apo1) enhance apoptosis in HPB-ALL cell line,” FEBS Letters, vol. 462, no. 3, pp. 322–328, 1999.
- B. Csokay, N. Prajda, G. Weber, and E. Olah, “Molecular mechanisms in the antiproliferative action of quercetin,” Life Sciences, vol. 60, no. 24, pp. 2157–2163, 1997.
- M. Yoshida, M. Yamamoto, and T. Nikaido, “Quercetin arrests human leukemic T-cells in late phase of the cell cycle,” Cancer Research, vol. 52, no. 23, pp. 6676–6681, 1992.
- D. R. Ferry, A. Smith, J. Malkhandi et al., “Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition,” Clinical Cancer Research, vol. 2, no. 4, pp. 659–668, 1996.
- N. Xing, Y. Chen, S. H. Mitchell, and C. Y. F. Young, “Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells,” Carcinogenesis, vol. 22, no. 3, pp. 409–414, 2001.
- E. Braganhol, L. L. Zamin, A. D. Canedo et al., “Antiproliferative effect of quercetin in the human U138MG glioma cell line,” Anti-Cancer Drugs, vol. 17, no. 6, pp. 663–671, 2006.
- Y. Wei, X. Zhao, Y. Kariya, H. Fukata, K. Teshigawara, and A. Uchida, “Induction of apoptosis by quercetin: involvement of heat shock protein,” Cancer Research, vol. 54, no. 18, pp. 4952–4957, 1994.
- Z. Ma, T. Hung Nguyen, T. Hoa Huynh, P. Tien Do, and H. Huynh, “Reduction of rat prostate weight by combined quercetin-finasteride treatment is associated with cell cycle deregulation,” Journal of Endocrinology, vol. 181, no. 3, pp. 493–507, 2004.
- I.-K. Wang, S.-Y. Lin-Shiau, and J.-K. Lin, “Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells,” European Journal of Cancer, vol. 35, no. 10, pp. 1517–1525, 1999.
- S. R. Datta, A. Brunet, and M. E. Greenberg, “Cellular survival: a play in three Akts,” Genes & Development, vol. 13, no. 22, pp. 2905–2927, 1999.
- D. Bernhard, I. Tinhofer, M. Tonko et al., “Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells,” Cell Death & Differentiation, vol. 7, no. 9, pp. 834–842, 2000.
- I. Murtaza, G. Marra, R. Schlapbach et al., “A preliminary investigation demonstrating the effect of quercetin on the expression of genes related to cell-cycle arrest, apoptosis and xenobiotic metabolism in human CO115 colon-adenocarcinoma cells using DNA microarray,” Biotechnology and Applied Biochemistry, vol. 45, no. 1, pp. 29–36, 2006.
- M. R. Vijayababu, A. Arunkumar, P. Kanagaraj, and J. Arunakaran, “Effects of quercetin on insulin-like growth factors (IGFs) and their binding protein-3 (IGFBP-3) secretion and induction of apoptosis in human prostate cancer cells,” Journal of Carcinogenesis, vol. 5, article 10, pp. 1–9, 2006.
- A. K. Joe, H. Liu, M. Suzui, M. E. Vural, D. Xiao, and I. B. Weinstein, “Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines,” Clinical Cancer Research, vol. 8, no. 3, pp. 893–903, 2002.
- F. D. Ragione, V. Cucciolla, A. Borriello et al., “Resveratrol arrests the cell division cycle at S/G2 phase transition,” Biochemical and Biophysical Research Communications, vol. 250, no. 1, pp. 53–58, 1998.
Copyright © 2008 Guoliang Cui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.